CA2071382A1 - Insulin analogs - Google Patents

Insulin analogs

Info

Publication number
CA2071382A1
CA2071382A1 CA002071382A CA2071382A CA2071382A1 CA 2071382 A1 CA2071382 A1 CA 2071382A1 CA 002071382 A CA002071382 A CA 002071382A CA 2071382 A CA2071382 A CA 2071382A CA 2071382 A1 CA2071382 A1 CA 2071382A1
Authority
CA
Canada
Prior art keywords
seq
xaa
asp
asn
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002071382A
Other languages
English (en)
French (fr)
Inventor
David N. Brems
Ronald E. Chance
Bruce H. Frank
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2071382A1 publication Critical patent/CA2071382A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Emergency Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA002071382A 1991-06-21 1992-06-17 Insulin analogs Abandoned CA2071382A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71857491A 1991-06-21 1991-06-21
US07/718,574 1991-06-21

Publications (1)

Publication Number Publication Date
CA2071382A1 true CA2071382A1 (en) 1992-12-22

Family

ID=24886590

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002071382A Abandoned CA2071382A1 (en) 1991-06-21 1992-06-17 Insulin analogs

Country Status (17)

Country Link
EP (1) EP0519750A3 (enExample)
JP (1) JPH05271283A (enExample)
CN (1) CN1069737A (enExample)
AU (1) AU1837792A (enExample)
BR (1) BR9202322A (enExample)
CA (1) CA2071382A1 (enExample)
CZ (1) CZ186492A3 (enExample)
FI (1) FI922882L (enExample)
HU (1) HUT61581A (enExample)
IE (1) IE921997A1 (enExample)
IL (1) IL102240A0 (enExample)
MX (1) MX9202987A (enExample)
NO (1) NO922376L (enExample)
NZ (1) NZ243229A (enExample)
TW (1) TW222643B (enExample)
YU (1) YU64192A (enExample)
ZA (1) ZA924448B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2151134A1 (en) * 1992-12-18 1994-07-07 Ronald Eugene Chance Insulin analogs
US20020111461A1 (en) 1999-05-21 2002-08-15 Todd C. Somers Low molecular weight peptidomimetic growth hormone secretagogues
AU4935701A (en) 2000-03-24 2001-10-08 Genentech Inc Use of insulin for the treatment of cartilagenous disorders
WO2006093222A1 (ja) * 2005-03-02 2006-09-08 Ajinomoto Co., Inc. インスリンの多量体形成阻害剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH25772A (en) * 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
ES2053723T3 (es) * 1987-02-25 1994-08-01 Novo Nordisk As Nuevos derivados de insulina.
US4992418A (en) * 1987-07-17 1991-02-12 Mount Sinai School Of Medicine Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin
IL93282A (en) * 1989-02-09 1995-08-31 Lilly Co Eli Insulin analogues

Also Published As

Publication number Publication date
EP0519750A3 (en) 1993-06-23
IL102240A0 (en) 1993-01-14
CN1069737A (zh) 1993-03-10
FI922882A7 (fi) 1992-12-22
CZ186492A3 (en) 1993-01-13
IE921997A1 (en) 1992-12-30
BR9202322A (pt) 1993-01-19
HUT61581A (en) 1993-01-28
NZ243229A (en) 1994-09-27
AU1837792A (en) 1992-12-24
NO922376L (no) 1992-12-22
NO922376D0 (no) 1992-06-17
FI922882L (fi) 1992-12-22
MX9202987A (es) 1993-01-01
JPH05271283A (ja) 1993-10-19
HU9202048D0 (en) 1992-09-28
ZA924448B (en) 1993-12-17
FI922882A0 (fi) 1992-06-18
TW222643B (enExample) 1994-04-21
YU64192A (sh) 1994-06-10
EP0519750A2 (en) 1992-12-23

Similar Documents

Publication Publication Date Title
EP0678522B1 (en) Insulin analogs
US6451970B1 (en) Peptide derivatives
US5559094A (en) AspB1 insulin analogs
Acher Molecular evolution of biologically active polypeptides
US5792747A (en) Highly potent agonists of growth hormone releasing hormone
US6025467A (en) Parathyroid hormone derivatives and their use
AU680462B2 (en) Insulin analogs
CZ289343B6 (cs) Inzulinový derivát a farmaceutický prostředek pro léčení diabetes
BG64815B1 (bg) Сайт - специфично получаване на конюгати от полиетилен- гликол - grf
OA11453A (en) Methods for treatment of diabetes using peptide analogues of insulin.
Inouye et al. Semisynthesis and properties of some insulin analogs
EP0433395A1 (en) Stable bioactive somatotropins
HU205145B (en) Process for producing new superactive insulin analogs and pharmaceutical compositions comprising same as active ingredient
US5149779A (en) Humoral hypercalcemic factor antagonists
WO1990000561A1 (en) Novel peptides
EP0796867B1 (en) Peptide, bronchodilator and blood flow ameliorant
EP0519750A2 (en) Insulin analogs
EP0002262B1 (en) Somatostatin analogs and process for their preparation
KR920005659B1 (ko) 인슐린 유도체의 제조방법
AU1804002A (en) Methods for treatment of diabetes using peptide analogues of insulin

Legal Events

Date Code Title Description
FZDE Discontinued